Robert Andrade | Chief Financial Officer |
Rostislav Raykov | Chief Executive Officer |
Adrian Haigh | Chief Operating Officer |
Chase Knickerbocker | Craig-Hallum Capital Group |
David Nierengarten | Wedbush Securities |
Good morning, ladies and gentlemen and welcome to the Fennec Pharmaceuticals Second Quarter 2023 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today's conference call is being recorded.
Now, I would like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade.
Thank you, operator and good morning, everyone.
We are delighted that you could join us today for Fennec Pharmaceuticals' second quarter 2023 earnings conference call.